Bank of America’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-349,600
Closed -$58.8M 7622
2019
Q3
$58.8M Buy
349,600
+283,300
+427% +$46.2M 0.01% 1015
2019
Q2
$11.1M Buy
66,300
+46,300
+232% +$6.41M ﹤0.01% 2444
2019
Q1
$2.93M Sell
20,000
-77,700
-80% -$11.3M ﹤0.01% 3668
2018
Q4
$13.1M Sell
97,700
-61,100
-38% -$10M ﹤0.01% 2043
2018
Q3
$30.2M Buy
158,800
+14,200
+10% +$2.61M ﹤0.01% 1494
2018
Q2
$24.1M Sell
144,600
-211,000
-59% -$33.9M ﹤0.01% 1655
2018
Q1
$59.8M Sell
355,600
-715,800
-67% -$120M 0.01% 941
2017
Q4
$175M Buy
1,071,400
+782,600
+271% +$140M 0.03% 493
2017
Q3
$59.2M Buy
288,800
+38,500
+15% +$8.95M 0.01% 1031
2017
Q2
$60.8M Sell
250,300
-10,400
-4% -$2.44M 0.01% 924
2017
Q1
$62.3M Sell
260,700
-419,500
-62% -$97.7M 0.01% 910
2016
Q4
$143M Buy
680,200
+140,800
+26% +$29.2M 0.03% 521
2016
Q3
$124M Sell
539,400
-8,800
-2% -$2.15M 0.03% 549
2016
Q2
$127M Buy
548,200
+326,600
+147% +$75.3M 0.03% 532
2016
Q1
$59.4M Sell
221,600
-47,000
-17% -$13.5M 0.01% 844
2015
Q4
$83.9M Buy
268,600
+139,700
+108% +$41.6M 0.02% 745
2015
Q3
$35M Sell
128,900
-54,400
-30% -$16.7M 0.01% 1206
2015
Q2
$55.6M Sell
183,300
-103,400
-36% -$30.8M 0.02% 796
2015
Q1
$85.3M Buy
286,700
+246,000
+604% +$70.1M 0.03% 578
2014
Q4
$10.5M Sell
40,700
-112,900
-74% -$28.2M ﹤0.01% 1896
2014
Q3
$37.1M Sell
153,600
-15,500
-9% -$3.47M 0.01% 1015
2014
Q2
$37.7M Buy
169,100
+131,500
+350% +$27.2M 0.01% 981
2014
Q1
$7.74M Buy
37,600
+25,500
+211% +$5.05M ﹤0.01% 1996
2013
Q4
$2.03M Buy
12,100
+11,600
+2,320% +$1.81M ﹤0.01% 3309
2013
Q3
$72K Sell
500
-1,600
-76% -$213K ﹤0.01% 6205
2013
Q2
$265K Buy
+2,100
New +$238K ﹤0.01% 5358

Other funds holding AGN

Bank of America's AGN Position: Q2 2020 in Review

Bank of America sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 8,432,014 shares — an estimated $1.49B sold.

Bank of America first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $1.49B in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Bank of America reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Bank of America sold 8,432,014 Allergan plc shares in Q2 2020, an estimated $1.49B.
  • Bank of America first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Bank of America's Allergan plc position peaked at $1.49B in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Bank of America's 13F filing for Q2 2020, filed 14 Aug 2020.